Xenetic Biosciences Inc. (XBIO)

AI Score

Unlock

2.46

-0.13 (-5.02%)

At close: Apr 04, 2025, 3:46 PM

2.46

0.00%

After-hours: Apr 04, 2025, 04:00 PM EDT

Dividends

No dividend history available for Xenetic Biosciences Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

XBIO News

1 week ago · Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into a Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Relapsed/Refractory Osteosarcoma and Ewing Sarcoma - accessnewswire.com
2 weeks ago · Xenetic Biosciences, Inc. Reports Full Year 2024 Financial Results - accessnewswire.com
3 weeks ago · Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses - accessnewswire.com
1 month ago · Xenetic Biosciences, Inc. Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting - accessnewswire.com